These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4671924)

  • 1. Inhibition of extrapyramidal side effects of haloperidol through the joint use of imipramine-type drugs.
    Butterworth AT
    Psychosomatics; 1972; 13(5):328-32. PubMed ID: 4671924
    [No Abstract]   [Full Text] [Related]  

  • 2. Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol.
    Altamura AC; Buccio M; Colacurcio F; Colombo G; Terzi A
    Acta Neurol (Napoli); 1986 Feb; 8(1):19-26. PubMed ID: 3962752
    [No Abstract]   [Full Text] [Related]  

  • 3. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P; Schmitz PJ; Ladee GA
    J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A double-blind study of metoclopramide in the treatment of schizophrenia and determination of prolactin].
    Gu SF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):328-30, 382. PubMed ID: 1304992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive versus monotherapeutic treatment for schizophrenia: addressing antipsychotic side effects.
    Hazra M; Mamo DC; Remington G
    Am J Psychiatry; 2008 Mar; 165(3):396-7; author reply 397-8. PubMed ID: 18316434
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
    Woggon B
    Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol in overt ambulatory schizophrenics.
    Darling HF
    Dis Nerv Syst; 1973; 34(7):364-7. PubMed ID: 4782293
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased extrapyramidal symptoms with intravenous haloperidol.
    Menza MA; Murray GB; Holmes VF; Rafuls WA
    J Clin Psychiatry; 1987 Jul; 48(7):278-80. PubMed ID: 3597329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of haloperidol.
    Man PL
    Dis Nerv Syst; 1973 Feb; 34(2):113-8. PubMed ID: 4267586
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevation of plasma concentrations of haloperidol after the addition of fluoxetine.
    Goff DC; Midha KK; Brotman AW; Waites M; Baldessarini RJ
    Am J Psychiatry; 1991 Jun; 148(6):790-2. PubMed ID: 2035723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotolysis with haloperidol. Rapid control of the acutely disturbed psychotic patient.
    Carter RG
    Dis Nerv Syst; 1977 Apr; 38(4):237-9. PubMed ID: 849701
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of outpatients with high doses of haloperidol].
    Shopsin B; Kline N
    Acta Psiquiatr Psicol Am Lat; 1981 Jul; 27(3):236-42. PubMed ID: 7348083
    [No Abstract]   [Full Text] [Related]  

  • 13. [The assessment of neuroleptogenic extrapyramidal syndroms in psychopharmacological research (author's transl)].
    Mattke DJ; Mombour W; Glötzner FL
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jan; 8(1):36-44. PubMed ID: 788001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics].
    Popov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):28-33. PubMed ID: 18577931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with haloperidol and orphenadrine in schizophrenia. A clinical and pharmacokinetic study.
    Altamura AC; Buccio M; Colombo G; Terzi A; Cazzullo CL
    Encephale; 1986; 12(1):31-6. PubMed ID: 3698889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H; Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1973; 76(4):251-9. PubMed ID: 4581374
    [No Abstract]   [Full Text] [Related]  

  • 17. [Extrapyamidal side-effects with 1-day dosage of haloperidol (author's transl)].
    Matzner G; Uriarte V; Rüther E
    Arzneimittelforschung; 1978; 28(9):1496-7. PubMed ID: 383097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre study on the efficacy and safety of individualized dosage of haloperidol (Haldol) in refractory chronic psychotics.
    Nicodeme A; Vranckx-Haenen J; Wouters J
    Acta Psychiatr Belg; 1977; 77(4):516-29. PubMed ID: 337756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol update: 1975.
    Ayd FJ
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):14-22. PubMed ID: 1019142
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study.
    Mann K; Bartels M; Gärtner HJ; Schied HW; Wagner W; Heimann H
    Pharmacopsychiatry; 1987 Jul; 20(4):155-9. PubMed ID: 2886997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.